Persistent NLRP3 inflammasome activation is associated with delayed immunosuppression in septic patients

J Leukoc Biol. 2024 Mar 29;115(4):706-713. doi: 10.1093/jleuko/qiad161.

Abstract

Sepsis triggers a complex response marked by the simultaneous presence of proinflammatory and immunosuppressive elements, disrupting the mechanisms intended to maintain homeostasis. While the NLRP3 inflammasome has been demonstrated to contribute to the inflammatory side, its connection with delayed sepsis-induced immunosuppression remains unexplored. The present objective was to concomitantly and prospectively assess NLRP3 activation (IL-1β, IL-18, and soluble receptors) and features of immune failure (IL-10, mHLA-DR, myeloid-derived suppressor cells) in septic patients. To validate our findings, we conducted a transcriptomic analysis of mRNA of NLRP3-related genes (IL-18R1, IL-1R2) on an additional cohort of 107 patients. Two distinct endotypes were identified. One cluster displayed moderate inflammation rapidly returning to normal values, while the other exhibited a higher inflammatory response persisting until day 28, which was associated with persistent marked immunosuppression and higher 28-d mortality. Identifying endotypes with different pro/anti-inflammatory trajectories could hold important clinical implications for the management of sepsis.

Keywords: MDSCs; NLRP3; immunosuppression; inflammation; mHLA-DR; sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunosuppression Therapy
  • Inflammasomes* / genetics
  • Interleukin-1beta / genetics
  • NLR Family, Pyrin Domain-Containing 3 Protein / genetics
  • Sepsis* / genetics

Substances

  • Inflammasomes
  • Interleukin-1beta
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human